ITRM20120169A1 - Dispositivo di rilascio di specie chimiche a controllo ottico - Google Patents

Dispositivo di rilascio di specie chimiche a controllo ottico

Info

Publication number
ITRM20120169A1
ITRM20120169A1 IT000169A ITRM20120169A ITRM20120169A1 IT RM20120169 A1 ITRM20120169 A1 IT RM20120169A1 IT 000169 A IT000169 A IT 000169A IT RM20120169 A ITRM20120169 A IT RM20120169A IT RM20120169 A1 ITRM20120169 A1 IT RM20120169A1
Authority
IT
Italy
Prior art keywords
chemical species
optical control
device release
release
controlled
Prior art date
Application number
IT000169A
Other languages
English (en)
Inventor
Paolo Matteini
Roberto Pini
Fulvio Ratto
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Priority to IT000169A priority Critical patent/ITRM20120169A1/it
Publication of ITRM20120169A1 publication Critical patent/ITRM20120169A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
IT000169A 2012-04-19 2012-04-19 Dispositivo di rilascio di specie chimiche a controllo ottico ITRM20120169A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT000169A ITRM20120169A1 (it) 2012-04-19 2012-04-19 Dispositivo di rilascio di specie chimiche a controllo ottico

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT000169A ITRM20120169A1 (it) 2012-04-19 2012-04-19 Dispositivo di rilascio di specie chimiche a controllo ottico
EP13727984.0A EP2838507B1 (en) 2012-04-19 2013-04-17 Matrix and device and use thereof for optically-controlled release of chemicals
US14/391,147 US20150086608A1 (en) 2012-04-19 2013-04-17 Matrix and device and use thereof for optically-controlled release of chemicals
PCT/IB2013/053044 WO2013156944A1 (en) 2012-04-19 2013-04-17 Matrix and device and use thereof for optically-controlled release of chemicals

Publications (1)

Publication Number Publication Date
ITRM20120169A1 true ITRM20120169A1 (it) 2013-10-20

Family

ID=46584154

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000169A ITRM20120169A1 (it) 2012-04-19 2012-04-19 Dispositivo di rilascio di specie chimiche a controllo ottico

Country Status (4)

Country Link
US (1) US20150086608A1 (it)
EP (1) EP2838507B1 (it)
IT (1) ITRM20120169A1 (it)
WO (1) WO2013156944A1 (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL201323D0 (en) 2009-10-01 2010-05-31 Medimop Medical Projects Ltd Fluid transfer device for assembling a vial with pre-attached female connector
IL202070D0 (en) 2009-11-12 2010-06-16 Medimop Medical Projects Ltd Inline liquid drug medical device
IL209290D0 (en) 2010-11-14 2011-01-31 Medimop Medical Projects Ltd Inline liquid drug medical device having rotary flow control member
IL215699D0 (en) 2011-10-11 2011-12-29 Medimop Medical Projects Ltd Liquid drug reconstitution assemblage for use with iv bag and drug vial
USD720451S1 (en) 2012-02-13 2014-12-30 Medimop Medical Projects Ltd. Liquid drug transfer assembly
USD737436S1 (en) 2012-02-13 2015-08-25 Medimop Medical Projects Ltd. Liquid drug reconstitution assembly
IL219065D0 (en) 2012-04-05 2012-07-31 Medimop Medical Projects Ltd Fluid transfer device with manual operated cartridge release arrangement
IL221634D0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Universal drug vial adapter
IL221635D0 (en) 2012-08-26 2012-12-31 Medimop Medical Projects Ltd Drug vial mixing and transfer device for use with iv bag and drug vial
JP5868555B2 (ja) 2012-09-13 2016-02-24 メディモップ・メディカル・プロジェクツ・リミテッド 入れ子式雌薬瓶アダプタ
USD734868S1 (en) 2012-11-27 2015-07-21 Medimop Medical Projects Ltd. Drug vial adapter with downwardly depending stopper
IL225734D0 (en) 2013-04-14 2013-09-30 Medimop Medical Projects Ltd Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor
US9943463B2 (en) 2013-05-10 2018-04-17 West Pharma. Services IL, Ltd. Medical devices including vial adapter with inline dry drug module
WO2014185863A1 (en) * 2013-05-15 2014-11-20 Agency For Science, Technology And Research A reversible thermo-initiated system
USD765837S1 (en) 2013-08-07 2016-09-06 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD767124S1 (en) 2013-08-07 2016-09-20 Medimop Medical Projects Ltd. Liquid transfer device with integral vial adapter
USD757933S1 (en) 2014-09-11 2016-05-31 Medimop Medical Projects Ltd. Dual vial adapter assemblage
BR112017013534A2 (pt) 2015-01-05 2018-03-06 Medimop Medical Projects Ltd montagens do adaptador de frasco duplo com adaptador de frasco de medicamento de rápida liberação para utilização correta
US10357429B2 (en) 2015-07-16 2019-07-23 West Pharma. Services IL, Ltd. Liquid drug transfer devices for secure telescopic snap fit on injection vials
USD801522S1 (en) 2015-11-09 2017-10-31 Medimop Medical Projects Ltd. Fluid transfer assembly
WO2017090042A1 (en) 2015-11-25 2017-06-01 Medimop Medical Projects Ltd Dual vial adapter assemblage including drug vial adapter with self-sealing access valve
USD832430S1 (en) 2016-11-15 2018-10-30 West Pharma. Services IL, Ltd. Dual vial adapter assemblage
WO2019185731A1 (en) 2018-03-28 2019-10-03 Università Degli Studi Di Milano - Bicocca Polymeric films containing nanoparticles endowed with photo-thermal effect and application thereof as thermal patches

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077330A1 (en) * 2004-02-17 2005-08-25 The University Of Melbourne Electromagnetic radiation addressable materials
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2690276B2 (ja) 1995-01-10 1997-12-10 科学技術振興事業団 静電結合型高分子ミセル薬物担体とその薬剤
US20050003008A1 (en) 1997-09-23 2005-01-06 Natalya Rapoport Method of in vivo drug targeting to solid tumors via acoustically triggered drug delivery in polymeric micelles
US6623430B1 (en) 1997-10-14 2003-09-23 Guided Therapy Systems, Inc. Method and apparatus for safety delivering medicants to a region of tissue using imaging, therapy and temperature monitoring ultrasonic system
US6726925B1 (en) 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US7425581B2 (en) 1999-07-30 2008-09-16 Universiteit Utrecht Temperature sensitive polymers
US20080181939A1 (en) * 1999-12-14 2008-07-31 Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
EP1418945A2 (en) 2001-03-13 2004-05-19 Angiotech Pharmaceuticals, Inc. Micellar drug delivery vehicles and uses thereof
JP2004532847A (ja) 2001-04-20 2004-10-28 ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア 疎水性薬物のためのミセル薬物送達システム
US20020192280A1 (en) * 2001-05-01 2002-12-19 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
US7018655B2 (en) 2002-03-18 2006-03-28 Labopharm, Inc. Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
WO2004098569A1 (en) 2003-04-18 2004-11-18 Northeastern University Micelle delivery system loaded with a pharmaceutical agent
WO2006062506A1 (en) 2004-12-03 2006-06-15 Enzrel, Inc. Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds
US8765116B2 (en) 2005-03-24 2014-07-01 Medifocus, Inc. Apparatus and method for pre-conditioning/fixation and treatment of disease with heat activation/release with thermoactivated drugs and gene products
JP2007139612A (ja) * 2005-11-18 2007-06-07 Fujifilm Corp 微細構造体、微細構造体の作製方法、ラマン分光法、及び装置
US20090004258A1 (en) 2007-06-27 2009-01-01 National Health Research Institutes Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field
JP2009051752A (ja) 2007-08-24 2009-03-12 Hitachi Ltd 磁性粒子含有薬剤キャリア及びそれを用いた治療装置
WO2009059449A1 (en) 2007-11-05 2009-05-14 Celsion Corporation Novel thermosensitive liposomes containing therapeutic agents
US20110230568A1 (en) 2008-07-24 2011-09-22 Childrens Medical Center Corporation Heating of polymers and other materials using radiation for drug delivery and other applications
US20100203150A1 (en) 2009-02-06 2010-08-12 National Tsing Hua University Novel amphiphilic copolymers and fabrication method thereof
EP2448557A1 (en) 2009-07-01 2012-05-09 Koninklijke Philips Electronics N.V. Stimuli-responsive carriers for mpi-guided drug delivery

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077330A1 (en) * 2004-02-17 2005-08-25 The University Of Melbourne Electromagnetic radiation addressable materials
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAASONEN ET AL: "Gold nanoparticles enable selective light-induced contents release from liposomes", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 122, no. 1, 22 August 2007 (2007-08-22), pages 86 - 93, XP022208580, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2007.06.009 *
PAOLO MATTEINI ET AL: "Chitosan Films Doped with Gold Nanorods as Laser-Activatable Hybrid Bioadhesives", ADVANCED MATERIALS, vol. 22, no. 38, 8 October 2010 (2010-10-08), pages 4313 - 4316, XP055047249, ISSN: 0935-9648, DOI: 10.1002/adma.201002228 *

Also Published As

Publication number Publication date
EP2838507B1 (en) 2018-05-30
EP2838507A1 (en) 2015-02-25
US20150086608A1 (en) 2015-03-26
WO2013156944A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
CR11199A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
DOP2018000088A (es) Amidas heterocíclicas como inhibidores de cinasas
UY33943A (es) Derivados espirocíclicos de isoxazolina como agentes antiparasitarios.
CL2012002189A1 (es) Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos.
CL2014001793A1 (es) Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer.
TR201816421T4 (tr) Kinaz modülasyonu için bileşikler ve metotlar ve bunların endikasyonları.
CY1119058T1 (el) Ενωσεισ ιμιδαζοπυρρολιδινονησ
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
CL2015000128A1 (es) Composición para controlar enfermedades en plantas y el uso de la misma
CO7000779A2 (es) Sistema de administración transdermica
TR201904345T4 (tr) Genetik Varyasyonları Non-İnvazif Değerlendirme Yöntemi
CL2015003280A1 (es) Derivados de benzimidazol como inhibidores de bromodominio
UY34607A (es) Plantas resistentes al glifosato y métodos asociados.
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CY1120318T1 (el) Υποκατεστημενεσ βενζυλινδαζολεσ για χρηση ωσ αναστολεισ κινασησ bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων
CL2015000808A1 (es) Formulaciones liquidas mejoradas de inhibidores de ureasa para fertilizantes.
DOP2015000274A (es) Compuestos químicos
SE1751350A1 (sv) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
AR090903A1 (es) Anticuerpos e inmunoconjugados anti-pmel17
UY34832A (es) TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda)
CR20150664A (es) Moduladores de los receptores de estrógeno y sus usos
CL2014002240A1 (es) Modulador del ligando de tipo delta 3 (dll3), particularmente un anticuerpo; ácido nucleico que lo codifica; célula huésped; conjugado de anticuerpo-fármaco antiproliferativo; uso para el tratamiento del cáncer; medicamento que lo comprende.
CY1120832T1 (el) Τροποποιητεσ πυρηνικησ μεταφορασ και χρησεισ αυτων
CL2014002873A1 (es) Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer.